Malignant mesothelioma as an oxidative stress-induced cancer: An update

Free Radical Biology and Medicine

Volumn 86, Issue , 2015, Pages 166-178

  Chew, Shan Hwu ^a   Toyokuni, Shinya ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Asbestos; Cancer stemcell; Iron; Malignant mesothelioma; MicroRNA

Indexed keywords

ASBESTOS; CA 125 ANTIGEN; HYALURONIC ACID; IRON; MESOTHELIN; MICRORNA; OSTEOPONTIN; TUMOR MARKER;

APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CHROMOSOME ABERRATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EARLY DIAGNOSIS; GENE EXPRESSION; GENOMICS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALIGNANT MESOTHELIOMA; MESOTHELIUM CELL; NONHUMAN; OXIDATIVE STRESS; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; ANIMAL; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; LUNG NEOPLASMS; MESOTHELIOMA; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALIA;

ANIMALS; ASBESTOS; BIOMARKERS, TUMOR; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84936751825     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.05.002     Document Type: Review

References (174)

1. A.R. Haas, and D.H. Sterman Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies Clin. Chest Med. 34 2013 99 111
2. V. Delgermaa, K. Takahashi, E.K. Park, G.V. Le, T. Hara, and T. Sorahan Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008 Bull. World Health Org. 89 2011 716 724
3. B.M. Robinson Malignant pleural mesothelioma: an epidemiological perspective Ann. Cardiothorac. Surg 1 2012 491 496
4. B.W. Robinson, and R.A. Lake Advances in malignant mesothelioma N. Engl. J. Med. 353 2005 1591 1603
5. P.E. Van Schil, I. Opitz, W. Weder, C. De Laet, A. Domen, P. Lauwers, J.M. Hendriks, and J.P. Van Meerbeeck Multimodal management of malignant pleural mesothelioma: where are we today? Eur. Respir. J. 44 2014 754 764
6. J.C. Wagner, C.A. Sleggs, and P. Marchand Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province Br. J. Ind. Med. 17 1960 260 271
7. Y. Grosse, D. Loomis, K.Z. Guyton, B. Lauby-Secretan, F. El Ghissassi, V. Bouvard, L. Benbrahim-Tallaa, N. Guha, and C. Scoccianti Mattock, H. Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes Lancet Oncol. 15 2014 1427 1428
8. A. Takagi, A. Hirose, T. Nishimura, N. Fukumori, A. Ogata, N. Ohashi, S. Kitajima, and J. Kanno Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube J. Toxicol. Sci. 33 2008 105 116
9. H. Nagai, Y. Okazaki, S.H. Chew, N. Misawa, Y. Yamashita, S. Akatsuka, T. Ishihara, K. Yamashita, Y. Yoshikawa, H. Yasui, L. Jiang, H. Ohara, T. Takahashi, G. Ichihara, K. Kostarelos, Y. Miyata, H. Shinohara, and S. Toyokuni Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis Proc. Natl. Acad. Sci. USA 108 2011 E1330 1338
10. S. Toyokuni Genotoxicity and carcinogenicity risk of carbon nanotubes Adv. Drug Deliv. Rev. 65 2013 2098 2110
11. M. Huncharek Non-asbestos related diffuse malignant mesothelioma Tumori 88 2002 1 9
12. D.D. Shersher, and M.J. Liptay Multimodality treatment of pleural mesothelioma Surg. Oncol. Clin. North Am 22 2013 345 355
13. S.E. Mutsaers Mesothelial cells: their structure, function and role in serosal repair Respirology 7 2002 171 191
14. H. Nagai, S.H. Chew, Y. Okazaki, S. Funahashi, T. Namba, T. Kato, A. Enomoto, L. Jiang, S. Akatsuka, and S. Toyokuni Metamorphosis of mesothelial cells with active horizontal motility in tissue culture Sci. Rep. 3 2013 1144
15. A.T. Raftery Regeneration of parietal and visceral peritoneum: an electron microscopical study J. Anat. 115 1973 375 392
16. S. Teranishi, M. Sakaguchi, and H. Itaya Mesothelial regeneration in the rat and effect of urokinase Nihon Geka Hokan 46 1977 361 379
17. D. Whitaker, and J. Papadimitriou Mesothelial healing: morphological and kinetic investigations J. Pathol. 145 1985 159 175
18. Z. Fotev, D. Whitaker, and J.M. Papadimitriou Role of macrophages in mesothelial healing J. Pathol. 151 1987 209 219
19. S.E. Mutsaers, D. Whitaker, and J.M. Papadimitriou Mesothelial regeneration is not dependent on subserosal cells J. Pathol. 190 2000 86 92
20. D. Aierken, Y. Okazaki, S.H. Chew, A. Sakai, Y. Wang, H. Nagai, N. Misawa, N. Kohyama, and S. Toyokuni Rat model demostrates a high risk of tremolite but a low risk of anthophyllite for mesothelial carcinogenesis Nagoya J. Med. Sci. 76 2014 149 160
21. A. Churg Fiber counting and analysis in the diagnosis of asbestos-related disease Hum. Pathol. 13 1982 381 392
22. A.D. McDonald, J.C. McDonald, and F.D. Pooley Mineral fibre content of lung in mesothelial tumours in North America Ann. Occup. Hyg. 26 1982 417 422
23. J.C. Wagner, M.L. Newhouse, B. Corrin, C.E.R. Rossiter, and D.M. Griffiths Correlation between fibre content of the lung and disease in east London asbestos factory workers Br. J. Ind. Med. 45 1988 305 308
24. B.T. Mossman, J. Bignon, M. Corn, A. Seaton, and J.B. Gee Asbestos: scientific developments and implications for public policy Science 247 1990 294 301
25. J.C. McDonald Epidemiology of malignant mesothelioma - an outline Ann. Occup. Hyg. 54 2010 851 857
26. M.S. Kanarek Mesothelioma from chrysotile asbestos: update Ann. Epidemiol. 21 2011 688 697
27. A.M. Langer, and W.T. McCaughey Mesothelioma in a brake repair worker Lancet 2 1982 1101 1103
28. K. Morinaga, N. Kohyama, K. Yokoyama, Y. Yasui, I. Hara, M. Sasaki, Y. Suzuki, and Y. Sera Asbestos fibre content of lungs with mesotheliomas in Osaka, Japan: a preliminary report IARC Sci. Publ. 1989 438 443
29. A.H. Smith, and C.C. Wright Chrysotile asbestos is the main cause of pleural mesothelioma Am. J. Ind. Med. 30 1996 252 266
30. A.L. Reeves, H.E. Puro, R.G. Smith, and A.J. Vorwald Experimental asbestos carcinogenesis Environ. Res. 4 1971 496 511
31. J.C. Wagner, G. Berry, and V. Timbrell Mesotheliomata in rats after inoculation with asbestos and other materials Br. J. Cancer 28 1973 173 185
32. L. Jiang, S. Akatsuka, H. Nagai, S.H. Chew, H. Ohara, Y. Okazaki, Y. Yamashita, Y. Yoshikawa, H. Yasui, K. Ikuta, K. Sasaki, Y. Kohgo, S. Hirano, Y. Shinohara, N. Kohyama, T. Takahashi, and S. Toyokuni Iron overload signature in chrysotile-induced malignant mesothelioma J. Pathol. 228 2012 366 377
33. L. Jiang, H. Nagai, H. Ohara, S. Hara, M. Tachibana, S. Hirano, Y. Shinohara, N. Kohyama, S. Akatsuka, and S. Toyokuni Characteristics and modifying factors of asbestos-induced oxidative DNA damage Cancer Sci. 99 2008 2142 2151
34. G. Macnab, and J.S. Harington Haemolytic activity of asbestos and other mineral dusts Nature 214 1967 522 523
35. R.J. Schnitzer, and F.L. Pundsack Asbestos hemolysis Environ. Res. 3 1970 1 13
36. J.S. Harington, K. Miller, and G. Macnab Hemolysis by asbestos Environ. Res. 4 1971 95 117
37. H. Nagai, T. Ishihara, W.H. Lee, H. Ohara, Y. Okazaki, K. Okawa, and S. Toyokuni Asbestos surface provides a niche for oxidative modification Cancer Sci. 102 2011 2118 2125
38. G. Miserocchi, G. Sancini, F. Mantegazza, and G. Chiappino Translocation pathways for inhaled asbestos fibers Environ. Health 7 2008 4
39. C. Boutin, P. Dumortier, F. Rey, J.R. Viallat, and P. De Vuyst Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study Am. J. Respir. Crit. Care Med. 153 1996 444 449
40. S. Toyokuni Mechanisms of asbestos-induced carcinogenesis Nagoya J. Med. Sci. 71 2009 1 10
41. S. Toyokuni Role of iron in carcinogenesis: cancer as a ferrotoxic disease Cancer Sci. 100 2009 9 16
42. D.W. Kamp, P. Graceffa, W.A. Pryor, and S.A. Weitzman The role of free radicals in asbestos-induced diseases Free Radic. Biol. Med. 12 1992 293 315
43. K.R. Maples, and N.F. Johnson Fiber-induced hydroxyl radical formation: correlation with mesothelioma induction in rats and humans Carcinogenesis 13 1992 2035 2039
44. H. Dong, A. Buard, A. Renier, F. Levy, L. Saint-Etienne, and M.C. Jaurand Role of oxygen derivatives in the cytotoxicity and DNA damage produced by asbestos on rat pleural mesothelial cells in vitro Carcinogenesis 15 1994 1251 1255
45. J.A. Hardy, and A.E. Aust The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks Carcinogenesis 16 1995 319 325
46. H. Fung, Y.W. Kow, B. Van Houten, and B.T. Mossman Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidative stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos Carcinogenesis 18 1997 825 832
47. S. Toyokuni, J.L. Sagripanti, and DNA Iron-mediated damage: sensitive detection of DNA strand breakage catalyzed by iron J. Inorg. Biochem. 47 1992 241 248
48. S. Toyokuni, and J.-L. Sagripanti DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis Carcinogenesis 14 1993 223 227
49. S. Toyokuni Iron-induced carcinogenesis: the role of redox regulation Free Radic. Biol. Med. 20 1996 553 566
50. K. Donaldson, F.A. Murphy, R. Duffin, and C.A. Poland Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma Part. Fibre Toxicol 7 2010 5
51. V. Levresse, A. Renier, F. Levy, V.C. Broaddus, and M. Jaurand DNA breakage in asbestos-treated normal and transformed (TSV40) rat pleural mesothelial cells Mutagenesis 15 2000 239 244
52. M. Yegles, L. Saint-Etienne, A. Renier, X. Janson, and M.C. Jaurand Induction of metaphase and anaphase/telophase abnormalities by asbestos fibers in rat pleural mesothelial cells in vitro Am. J. Respir. Cell Mol. Biol. 9 1993 186 191
53. E. Dopp, J. Saedler, H. Stopper, D.G. Weiss, and D. Schiffmann Mitotic disturbances and micronucleus induction in Syrian hamster embryo fibroblast cells caused by asbestos fibers Environ. Health Perspect. 103 1995 268 271
54. C.G. Jensen, L.C. Jensen, C.L. Rieder, R.W. Cole, and J.G. Ault Long crocidolite asbestos fibers cause polyploidy by sterically blocking cytokinesis Carcinogenesis 17 1996 2013 2021
55. R.A. MacCorkle, S.D. Slattery, D.R. Nash, and B.R. Brinkley Intracellular protein binding to asbestos induces aneuploidy in human lung fibroblasts Cell Motil. Cytoskeleton 63 2006 646 657
56. K. Yamashita, H. Nagai, and S. Toyokuni Receptor role of annexin A2 in the mesothelial endocytosis of crocidolite fibers Lab. Invest 95 2015 749 764
57. A.M. Boylan, D.A. Sanan, D. Sheppard, and V.C. Broaddus Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5 J. Clin. Invest. 96 1995 1987 2001
58. B.T. Mossman, A. Eastman, J.M. Landesman, and E. Bresnick Effects of crocidolite and chrysotile asbestos on cellular uptake and metabolism of benzo(a)pyrene in hamster tracheal epithelial cells Environ. Health Perspect. 51 1983 331 335
59. D. McFadden, J. Wright, B. Wiggs, and A. Churg Cigarette smoke increases the penetration of asbestos fibers into airway walls Am. J. Pathol. 123 1986 95 99
60. Y. Kubo, H. Takenaka, H. Nagai, and S. Toyokuni Distinct affinity of nuclear proteins to the surface of chrysotile and crocidolite J. Clin. Biochem. Nutr. 51 2012 221 226
61. S. Toyokuni Iron as a target of chemoprevention for longevity in humans Free Radic. Res. 45 2011 906 917
62. S. Toyokuni Iron and thiols as two major players in carcinogenesis: friends or foes? Front. Pharmacol 5 2014 200
63. I. Poser, Q. Rahman, M. Lohani, S. Yadav, H.H. Becker, D.G. Weiss, D. Schiffmann, and E. Dopp Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor Mutat. Res. 559 2004 19 27
64. A. Xu, L.B. Smilenov, P. He, K. Masumura, T. Nohmi, Z. Yu, and T.K. Hei New insight into intrachromosomal deletions induced by chrysotile in the gpt delta transgenic mutation assay Environ. Health Perspect. 115 2007 87 92
65. J.Q. Cheng, S.C. Jhanwar, W.M. Klein, D.W. Bell, W.C. Lee, D.A. Altomare, T. Nobori, O.I. Olopade, A.J. Buckler, and J.R. Testa p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma Cancer Res. 54 1994 5547 5551
66. S. Xio, D. Li, J. Vijg, D.J. Sugarbaker, J.M. Corson, and J.A. Fletcher Codeletion of p15 and p16 in primary malignant mesothelioma Oncogene 11 1995 511 515
67. P.B. Illei, M. Ladanyi, V.W. Rusch, and M.F. Zakowski The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions Cancer 99 2003 51 56
68. T. Taniguchi, S. Karnan, T. Fukui, T. Yokoyama, H. Tagawa, K. Yokoi, Y. Ueda, T. Mitsudomi, Y. Horio, T. Hida, Y. Yatabe, M. Seto, and Y. Sekido Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32 Cancer Sci. 98 2007 438 446
69. D.A. Altomare, C.A. Vaslet, K.L. Skele, A. De Rienzo, K. Devarajan, S.C. Jhanwar, A.I. McClatchey, A.B. Kane, and J.R. Testa A mouse model recapitulating molecular features of human mesothelioma Cancer Res. 65 2005 8090 8095
70. D. Jean, E. Thomas, E. Manie, A. Renier, A. de Reynies, C. Lecomte, P. Andujar, J. Fleury-Feith, F. Galateau-Salle, M. Giovannini, J. Zucman-Rossi, M.H. Stern, and M.C. Jaurand Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma Am. J. Pathol. 178 2011 881 894
71. S. Akatsuka, Y. Yamashita, H. Ohara, Y.T. Liu, M. Izumiya, K. Abe, M. Ochiai, L. Jiang, H. Nagai, Y. Okazaki, H. Murakami, Y. Sekido, E. Arai, Y. Kanai, O. Hino, T. Takahashi, H. Nakagama, and S. Toyokuni Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer PLoS One 7 2012 e43403
72. Q. Hu, S. Akatsuka, Y. Yamashita, H. Ohara, H. Nagai, Y. Okazaki, T. Takahashi, and S. Toyokuni Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma Lab. Invest. 90 2010 360 373
73. S. Toyokuni Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis Redox Rep. 19 2013 1 7
74. C.O. Hanemann Magic but treatable? Tumours due to loss of merlin Brain 131 2008 606 615
75. A.B. Bianchi, S.I. Mitsunaga, J.Q. Cheng, W.M. Klein, S.C. Jhanwar, B. Seizinger, N. Kley, A.J. Klein-Szanto, and J.R. Testa High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas Proc. Natl. Acad. Sci. USA 92 1995 10854 10858
76. Y. Sekido, H.I. Pass, S. Bader, D.J. Mew, M.F. Christman, A.F. Gazdar, and J.D. Minna Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer Cancer Res. 55 1995 1227 1231
77. T. Yokoyama, H. Osada, H. Murakami, Y. Tatematsu, T. Taniguchi, Y. Kondo, Y. Yatabe, Y. Hasegawa, K. Shimokata, Y. Horio, T. Hida, and Y. Sekido YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation Carcinogenesis 29 2008 2139 2146
78. M. Suzuki, S. Toyooka, N. Shivapurkar, H. Shigematsu, K. Miyajima, T. Takahashi, V. Stastny, A.L. Zern, T. Fujisawa, H.I. Pass, M. Carbone, and A.F. Gazdar Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection Oncogene 24 2005 1302 1308
79. H. Donninger, M.D. Vos, and G.J. Clark The RASSF1A tumor suppressor J. Cell Sci. 120 2007 3163 3172
80. M.S. Huen, S.M. Sy, and J. Chen BRCA1 and its toolbox for the maintenance of genome integrity Nat. Rev. Mol. Cell Biol. 11 2010 138 148
81. S.R. Stecklein, E. Kumaraswamy, F. Behbod, W. Wang, V. Chaguturu, L.M. Harlan-Williams, R.A. Jensen, and BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation Proc. Natl. Acad. Sci. USA 109 2012 13650 13655
82. S. Toyokuni, T. Mori, and M. Dizdaroglu DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate Int. J. Cancer 57 1994 123 128
83. S. Toyokuni, T. Mori, H. Hiai, and M. Dizdaroglu Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin Int. J. Cancer 62 1995 309 313
84. S. Toyokuni, and J.-L. Sagripanti Association between 8-hydroxy-2′-deoxyguanosine formation and DNA strand breaks mediated by copper and iron Free Radic. Biol. Med. 20 1996 859 864
85. M. Bott, M. Brevet, B.S. Taylor, S. Shimizu, T. Ito, L. Wang, J. Creaney, R.A. Lake, M.F. Zakowski, B. Reva, C. Sander, R. Delsite, S. Powell, Q. Zhou, R. Shen, A. Olshen, V. Rusch, and M. Ladanyi The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma Nat. Genet. 43 2011 668 672
86. J.R. Testa, M. Cheung, J. Pei, J.E. Below, Y. Tan, E. Sementino, N.J. Cox, A.U. Dogan, H.I. Pass, S. Trusa, M. Hesdorffer, M. Nasu, A. Powers, Z. Rivera, S. Comertpay, M. Tanji, G. Gaudino, H. Yang, and M. Carbone Germline BAP1 mutations predispose to malignant mesothelioma Nat. Genet. 43 2011 1022 1025
87. T. Wiesner, I. Fried, P. Ulz, E. Stacher, H. Popper, R. Murali, H. Kutzner, S. Lax, F. Smolle-Juttner, J.B. Geigl, and M.R. Speicher Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations J. Clin. Oncol. 30 2012 e337 340
88. S. Akatsuka, T.T. Aung, K.K. Dutta, L. Jiang, W.H. Lee, Y.T. Liu, J. Onuki, T. Shirase, K. Yamasaki, H. Ochi, Y. Naito, T. Yoshikawa, H. Kasai, Y. Tominaga, K. Sakumi, Y. Nakabeppu, Y. Kawai, K. Uchida, A. Yamasaki, T. Tsuruyama, Y. Yamada, and S. Toyokuni Contrasting genome-wide distribution of 8-hydroxyguanine and acrolein-modified adenine during oxidative stress-induced renal carcinogenesis Am. J. Pathol. 169 2006 1328 1342
89. S. Akatsuka, and S. Toyokuni Genome-scale approaches to investigate oxidative DNA damage J. Clin. Biochem. Nutr. 47 2010 91 97
90. M. Yoshihara, L. Jiang, S. Akatsuka, M. Suyama, and S. Toyokuni Genome-wide profiling of 8-oxoguanine reveals its association with spatial positioning in nucleus DNA Res. 21 2014 603 612
91. L.A. Goodglick, and A.B. Kane Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages Cancer Res. 46 1986 5558 5566
92. W. Liu, J.D. Ernst, and V.C. Broaddus Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells Am. Respir. Cell Mol. Biol 23 2000 371 378
93. S.H. Chew, Y. Okazaki, H. Nagai, N. Misawa, S. Akatsuka, K. Yamashita, L. Jiang, Y. Yamashita, M. Noguchi, K. Hosoda, Y. Sekido, T. Takahashi, and S. Toyokuni Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production Carcinogenesis 35 2013 164 172
94. C.L. Zanella, J. Posada, T.R. Tritton, and B.T. Mossman Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor Cancer Res. 56 1996 5334 5338
95. 2 Am. J. Physiol. 273 1997 L1029 L1035
96. N.H. Heintz, Y.M. Janssen, and B.T. Mossman Persistent induction of c-fos and c-jun expression by asbestos Proc. Natl. Acad. Sci. USA 90 1993 3299 3303
97. T.R. Quinlan, K.A. BeruBe, J.P. Marsh, Y.M. Janssen, P. Taishi, K.O. Leslie, D. Hemenway, P.T. O'Shaughnessy, P. Vacek, and B.T. Mossman Patterns of inflammation, cell proliferation, and related gene expression in lung after inhalation of chrysotile asbestos Am. J. Pathol. 147 1995 728 739
98. C.L. Zanella, C.R. Timblin, A. Cummins, M. Jung, J. Goldberg, R. Raabe, T.R. Tritton, and B.T. Mossman Asbestos-induced phosphorylation of epidermal growth factor receptor is linked to c-fos and apoptosis Am. J. Physiol. 277 1999 L684 693
99. A. Barchowsky, R.R. Roussel, R.J. Krieser, B.T. Mossman, and M.D. Treadwell Expression and activity of urokinase and its receptor in endothelial and pulmonary epithelial cells exposed to asbestos Toxicol. Appl. Pharmacol. 152 1998 388 396
100. D.M. Brown, P.H. Beswick, and K. Donaldson Induction of nuclear translocation of NF-kappaB in epithelial cells by respirable mineral fibres J. Pathol. 189 1999 258 264
101. N. Cheng, X. Shi, J. Ye, V. Castranova, F. Chen, S.S. Leonard, V. Vallyathan, and Y. Rojanasakul Role of transcription factor NF-kappaB in asbestos-induced TNFalpha response from macrophages Exp. Mol. Pathol. 66 1999 201 210
102. H. Yang, M. Bocchetta, B. Kroczynska, A.G. Elmishad, Y. Chen, Z. Liu, C. Bubici, B.T. Mossman, H.I. Pass, J.R. Testa, G. Franzoso, and M. Carbone TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis Proc. Natl. Acad. Sci. USA 103 2006 10397 10402
103. J.C. Pache, Y.M. Janssen, E.S. Walsh, T.R. Quinlan, C.L. Zanella, R.B. Low, D.J. Taatjes, and B.T. Mossman Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers Am. J. Pathol. 152 1998 333 340
104. R. Jagadeeswaran, P.C. Ma, T.Y. Seiwert, S. Jagadeeswaran, O. Zumba, V. Nallasura, S. Ahmed, R. Filiberti, M. Paganuzzi, R. Puntoni, R.A. Kratzke, G.J. Gordon, D.J. Sugarbaker, R. Bueno, V. Janamanchi, V.P. Bindokas, H.L. Kindler, and R. Salgia Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma Cancer Res. 66 2006 352 361
105. A. Destro, G.L. Ceresoli, M. Falleni, P.A. Zucali, E. Morenghi, P. Bianchi, C. Pellegrini, N. Cordani, V. Vaira, M. Alloisio, A. Rizzi, S. Bosari, and M. Roncalli EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations Lung Cancer 51 2006 207 215
106. H. Murakami, T. Mizuno, T. Taniguchi, M. Fujii, F. Ishiguro, T. Fukui, S. Akatsuka, Y. Horio, T. Hida, Y. Kondo, S. Toyokuni, H. Osada, and Y. Sekido LATS2 is a tumor suppressor gene of malignant mesothelioma Cancer Res. 71 2011 873 883
107. M. Fujii, T. Toyoda, H. Nakanishi, Y. Yatabe, A. Sato, Y. Matsudaira, H. Ito, H. Murakami, Y. Kondo, E. Kondo, T. Hida, T. Tsujimura, H. Osada, and Y. Sekido TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth J. Exp. Med. 209 2012 479 494
108. L. Jiang, Y. Yamashita, S.H. Chew, S. Akatsuka, S. Ukai, S. Wang, H. Nagai, Y. Okazaki, T. Takahashi, and S. Toyokuni Connective tissue growth factor and beta-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma J. Pathol. 233 2014 402 414
109. D. Shao, P. Zhai, D.P. Del Re, S. Sciarretta, N. Yabuta, H. Nojima, D. Lim, D. Pan, and J. Sadoshima A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response Nat. Commun 5 2014 3315
110. C. Dostert, V. Petrilli, R. Van Bruggen, C. Steele, B.T. Mossman, and J. Tschopp Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica Science 320 2008 674 677
111. J.K. Thompson, C.M. Westbom, M.B. MacPherson, B.T. Mossman, N.H. Heintz, P. Spiess, and A. Shukla Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation Part. Fibre Toxicol 11 2014 24
112. J.M. Miller, J.K. Thompson, M.B. MacPherson, S.L. Beuschel, C.M. Westbom, M. Sayan, and A. Shukla Curcumin: a double hit on malignant mesothelioma Cancer Prev. Res 7 2014 330 340
113. H. Yang, Z. Rivera, S. Jube, M. Nasu, P. Bertino, C. Goparaju, G. Franzoso, M.T. Lotze, T. Krausz, H.I. Pass, M.E. Bianchi, and M. Carbone Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation Proc. Natl. Acad. Sci. USA 107 2010 12611 12616
114. F. Di Virgilio The therapeutic potential of modifying inflammasomes and NOD-like receptors Pharmacol. Rev. 65 2013 872 905
115. S. Jube, Z.S. Rivera, M.E. Bianchi, A. Powers, E. Wang, I. Pagano, H.I. Pass, G. Gaudino, M. Carbone, and H. Yang Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma Cancer Res. 72 2012 3290 3301
116. Y. Wang, S.P. Faux, G. Hallden, D.H. Kirn, C.E. Houghton, N.R. Lemoine, and G. Patrick Interleukin-1beta and tumour necrosis factor-alpha promote the transformation of human immortalised mesothelial cells by erionite Int. J. Oncol. 25 2004 173 178
117. F. Qi, G. Okimoto, S. Jube, A. Napolitano, H.I. Pass, R. Laczko, R.M. Demay, G. Khan, M. Tiirikainen, C. Rinaudo, A. Croce, H. Yang, G. Gaudino, and M. Carbone Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-alpha signaling Am. J. Pathol. 183 2013 1654 1666
118. D. Tang, R. Kang, H.J. Zeh 3rd, and M.T. Lotze High-mobility group box 1, oxidative stress, and disease Antioxid. Redox Signal. 14 2011 1315 1335
119. Y. Yu, D. Tang, and R. Kang Oxidative stress-mediated HMGB1 biology Front. Physiol. 6 2015 93
120. K. Newick, B. Cunniff, K. Preston, P. Held, J. Arbiser, H. Pass, B. Mossman, A. Shukla, and N. Heintz Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells PLoS One 7 2012 e39404
121. B. Cunniff, A.N. Wozniak, P. Sweeney, K. DeCosta, and N.H. Heintz Peroxiredoxin 3 levels regulate a mitochondrial redox setpoint in malignant mesothelioma cells Redox Biol 3 2014 79 87
122. B. Cunniff, K. Benson, J. Stumpff, K. Newick, P. Held, D. Taatjes, J. Joseph, B. Kalyanaraman, and N.H. Heintz Mitochondrial-targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells J. Cell. Physiol. 228 2013 835 845
123. D. Valenti, L. de Bari, G.A. Manente, L. Rossi, L. Mutti, L. Moro, and R.A. Vacca Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells Biochim. Biophys. Acta 1832 2013 2085 2096
124. T. Tatsuta, M. Hosono, S. Sugawara, Y. Kariya, Y. Ogawa, S. Hakomori, and K. Nitta Sialic acid-binding lectin (leczyme) induces caspase-dependent apoptosis-mediated mitochondrial perturbation in Jurkat cells Int. J. Oncol. 43 2013 1402 1412
125. J.H. t. Stewart, T.L. Tran, N. Levi, W.S. Tsai, D.S. Schrump, and D.M. Nguyen The essential role of the mitochondria and reactive oxygen species in cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma J. Surg. Res. 141 2007 120 131
126. J. Kovarova, M. Bajzikova, M. Vondrusova, J. Stursa, J. Goodwin, M. Nguyen, R. Zobalova, E.A. Pesdar, J. Truksa, M. Tomasetti, L.F. Dong, and J. Neuzil Mitochondrial targeting of alpha-tocopheryl succinate enhances its anti-mesothelioma efficacy Redox Rep. 19 2014 16 25
127. W. Aung, S. Hasegawa, T. Furukawa, and T. Saga Potential role of ferritin heavy chain in oxidative stress and apoptosis in human mesothelial and mesothelioma cells: implications for asbestos-induced oncogenesis Carcinogenesis 28 2007 2047 2052
128. C. Tabata, T. Terada, R. Tabata, S. Yamada, R. Eguchi, Y. Fujimori, and T. Nakano Serum thioredoxin-1 as a diagnostic marker for malignant peritoneal mesothelioma J. Clin. Gastroenterol. 47 2013 e7 11
129. F. Vandermeers, P. Hubert, P. Delvenne, C. Mascaux, B. Grigoriu, A. Burny, A. Scherpereel, and L. Willems Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma Clin. Cancer Res. 15 2009 2818 2828
130. C. Frei, I. Opitz, A. Soltermann, B. Fischer, U. Moura, H. Rehrauer, W. Weder, R. Stahel, and E. Felley-Bosco Pleural mesothelioma side populations have a precursor phenotype Carcinogenesis 32 2011 1324 1332
131. S. Varghese, R. Whipple, S.S. Martin, and H.R. Alexander Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesis PLoS One 7 2012 e52825
132. H. Yamazaki, M. Naito, F.I. Ghani, N.H. Dang, S. Iwata, and C. Morimoto Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells Biochem. Biophys. Res. Commun. 419 2012 529 536
133. L. Cortes-Dericks, G.L. Carboni, R.A. Schmid, and G. Karoubi Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed Int. J. Oncol. 37 2010 437 444
134. T. Ishimoto, O. Nagano, T. Yae, M. Tamada, T. Motohara, H. Oshima, M. Oshima, T. Ikeda, R. Asaba, H. Yagi, T. Masuko, T. Shimizu, T. Ishikawa, K. Kai, E. Takahashi, Y. Imamura, Y. Baba, M. Ohmura, M. Suematsu, H. Baba, and H. Saya CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth Cancer Cell 19 2011 387 400
135. M.C. Kim, F.J. Cui, and Y. Kim Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells Asian Pac. J. Cancer Prev. 14 2013 3625 3630
136. H.B. Lee, and H. Ha Mechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis J. Korean Med. Sci. 22 2007 943 945
137. A.K. Leung, and P.A. Sharp MicroRNA functions in stress responses Mol. Cell 40 2010 205 215
138. M. Tomasetti, L. Nocchi, S. Staffolani, N. Manzella, M. Amati, J. Goodwin, K. Kluckova, M. Nguyen, E. Strafella, M. Bajzikova, M. Peterka, S. Lettlova, J. Truksa, W. Lee, L.F. Dong, L. Santarelli, and J. Neuzil MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function Antioxid. Redox Signal. 21 2014 2109 2125
139. L. Santarelli, E. Strafella, S. Staffolani, M. Amati, M. Emanuelli, D. Sartini, V. Pozzi, D. Carbonari, M. Bracci, E. Pignotti, P. Mazzanti, A. Sabbatini, R. Ranaldi, S. Gasparini, J. Neuzil, and M. Tomasetti Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma PLoS One 6 2011 e18232
140. D.G. Weber, G. Johnen, O. Bryk, K.H. Jockel, and T. Bruning Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma - a pilot study. PLoS One 7 2012 e30221
141. H. Benjamin, D. Lebanony, S. Rosenwald, L. Cohen, H. Gibori, N. Barabash, K. Ashkenazi, E. Goren, E. Meiri, S. Morgenstern, M. Perelman, I. Barshack, Y. Goren, T.B. Edmonston, A. Chajut, R. Aharonov, Z. Bentwich, N. Rosenfeld, and D. Cohen A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma J. Mol. Diagn. 12 2010 771 779
142. G.V. Gee, D.C. Koestler, B.C. Christensen, D.J. Sugarbaker, D. Ugolini, G.P. Ivaldi, M.B. Resnick, E.A. Houseman, K.T. Kelsey, and C.J. Marsit Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma Int. J. Cancer 127 2010 2859 2869
143. S. Busacca, S. Germano, L. De Cecco, M. Rinaldi, F. Comoglio, F. Favero, B. Murer, L. Mutti, M. Pierotti, and G. Gaudino MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications Am. J. Respir. Cell Mol. Biol. 42 2010 312 319
144. M. Guled, L. Lahti, P.M. Lindholm, K. Salmenkivi, I. Bagwan, A.G. Nicholson, and S. Knuutila CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis Gene Chromosome Cancer 48 2009 615 623
145. S.V. Ivanov, C.M. Goparaju, P. Lopez, J. Zavadil, G. Toren-Haritan, S. Rosenwald, M. Hoshen, A. Chajut, D. Cohen, and H.I. Pass Pro-tumorigenic effects of miR-31 loss in mesothelioma J. Biol. Chem. 285 2010 22809 22817
146. E. Mogilyansky, and I. Rigoutsos The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease Cell Death Differ. 20 2013 1603 1614
147. V. Balatti, S. Maniero, M. Ferracin, A. Veronese, M. Negrini, G. Ferrocci, F. Martini, and M.G. Tognon MicroRNAs dysregulation in human malignant pleural mesothelioma J. Thorac. Oncol. 6 2011 844 851
148. L. Zacharski, B. Chow, P. Howes, G. Shamayeva, J. Baron, R. Dalman, D. Malenka, C. Ozaki, and P. Levori Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial J. Natl. Cancer Inst. 100 2008 996 1002
149. H. Nagai, Y. Okazaki, S.H. Chew, N. Misawa, H. Yasui, and S. Toyokuni Deferasirox induces mesenchymal-epithelial transition in crocidolite-induced mesothelial carcinogenesis in rats Cancer Prev. Res 6 2013 1222 1230
150. T. Frebourg, G. Lerebours, B. Delpech, D. Benhamou, P. Bertrand, C. Maingonnat, C. Boutin, and G. Nouvet Serum hyaluronate in malignant pleural mesothelioma Cancer 59 1987 2104 2107
151. T. Pettersson, B. Froseth, H. Riska, and M. Klockars Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma Chest 94 1988 1037 1039
152. B. Grigoriu, B. Chahine, F. Zerimech, M. Gregoire, M. Balduyck, M.C. Copin, P. Devos, P. Lassalle, and A. Scherpereel Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma Clin. Biochem. 42 2009 1046 1050
153. B.D. Grigoriu, A. Scherpereel, P. Devos, B. Chahine, M. Letourneux, P. Lebailly, M. Gregoire, H. Porte, M.C. Copin, and P. Lassalle Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment Clin. Cancer Res. 13 2007 2928 2935
154. J. Creaney, D. Yeoman, Y. Demelker, A. Segal, A.W. Musk, S.J. Skates, and B.W. Robinson Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma J. Thorac. Oncol. 3 2008 851 857
155. K. Iwahori, T. Osaki, S. Serada, M. Fujimoto, H. Suzuki, Y. Kishi, A. Yokoyama, H. Hamada, Y. Fujii, K. Yamaguchi, T. Hirashima, K. Matsui, I. Tachibana, Y. Nakamura, I. Kawase, and T. Naka Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin Lung Cancer 62 2008 45 54
156. I. Pantazopoulos, P. Boura, T. Xanthos, and K. Syrigos Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma Eur. Respir. J. 41 2013 706 715
157. A. Cui, X.G. Jin, K. Zhai, Z.H. Tong, and H.Z. Shi Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis BMJ Open 4 2014 e004145
158. K. Hollevoet, K. Nackaerts, J. Thimpont, P. Germonpre, L. Bosquee, P. De Vuyst, C. Legrand, E. Kellen, Y. Kishi, J.R. Delanghe, and J.P. van Meerbeeck Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma Am. J. Respir. Crit. Care Med. 181 2010 620 625
159. M. Ray, and H.L. Kindler Malignant pleural mesothelioma: an update on biomarkers and treatment Chest 136 2009 888 896
160. A. Cristaudo, A. Bonotti, S. Simonini, R. Bruno, and R. Foddis Soluble markers for diagnosis of malignant pleural mesothelioma Biomark. Med. 5 2011 261 273
161. J. Creaney, S. Sneddon, I.M. Dick, H. Dare, N. Boudville, A.W. Musk, S.J. Skates, and B.W. Robinson Comparison of the diagnostic accuracy of the MSLN gene products, mesothelin and megakaryocyte potentiating factor, as biomarkers for mesothelioma in pleural effusions and serum Dis. Markers 35 2013 119 127
162. S. van der Bij, E. Schaake, H. Koffijberg, J.A. Burgers, B.A. de Mol, and K.G. Moons Markers for the non-invasive diagnosis of mesothelioma: a systematic review Br. J. Cancer 104 2011 1325 1333
163. K. Hollevoet, J.B. Reitsma, J. Creaney, B.D. Grigoriu, B.W. Robinson, A. Scherpereel, A. Cristaudo, H.I. Pass, K. Nackaerts, J.A. Rodriguez Portal, J. Schneider, T. Muley, F. Di Serio, P. Baas, M. Tomasetti, A.J. Rai, and J.P. van Meerbeeck Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis J. Clin. Oncol. 30 2012 1541 1549
164. J. Creaney, I. van Bruggen, M. Hof, A. Segal, A.W. Musk, N. de Klerk, N. Horick, S.J. Skates, and B.W. Robinson Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma Chest 132 2007 1239 1246
165. J. Creaney, D. Yeoman, A.W. Musk, N. de Klerk, S.J. Skates, and B.W. Robinson Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma - which is best? Lung Cancer 74 2011 55 60
166. K. Fukuoka, K. Kuribayashi, S. Yamada, K. Tamura, C. Tabata, and T. Nakano Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma Mol. Clin. Oncol. 1 2013 942 948
167. D.G. Weber, S. Casjens, G. Johnen, O. Bryk, I. Raiko, B. Pesch, J. Kollmeier, T.T. Bauer, and T. Bruning Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis PLoS One 9 2014 e114483
168. C. Tabata, E. Shibata, R. Tabata, S. Kanemura, K. Mikami, Y. Nogi, E. Masachika, T. Nishizaki, and T. Nakano Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma BMC Cancer 13 2013 205
169. H.I. Pass, S.M. Levin, M.R. Harbut, J. Melamed, L. Chiriboga, J. Donington, M. Huflejt, M. Carbone, D. Chia, L. Goodglick, G.E. Goodman, M.D. Thornquist, G. Liu, M. de Perrot, M.S. Tsao, and C. Goparaju Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma N. Engl. J. Med. 367 2012 1417 1427
170. J. Creaney, I.M. Dick, T.M. Meniawy, S.L. Leong, J.S. Leon, Y. Demelker, A. Segal, A.W. Musk, Y.C. Lee, S.J. Skates, A.K. Nowak, and B.W. Robinson Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma Thorax 69 2014 895 902
171. R.M. Ostroff, M.R. Mehan, A. Stewart, D. Ayers, E.N. Brody, S.A. Williams, S. Levin, B. Black, M. Harbut, M. Carbone, C. Goparaju, and H.I. Pass Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool PLoS One 7 2012 e46091
172. Y. Okazaki, H. Nagai, S.H. Chew, J. Li, S. Funahashi, T. Tsujimura, and S. Toyokuni CD146 and insulin-like growth factor 2 mRNA-binding protein 3 predict prognosis of asbestos-induced rat mesothelioma Cancer Sci. 104 2013 989 995
173. A. Sato, I. Torii, Y. Okamura, T. Yamamoto, T. Nishigami, T.R. Kataoka, M. Song, S. Hasegawa, T. Nakano, T. Kamei, and T. Tsujimura Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium Mod. Pathol. 23 2010 1458 1466
174. M. Shi, A.E. Fraire, P. Chu, K. Cornejo, B.A. Woda, K. Dresser, K.L. Rock, and Z. Jiang Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation Am. J. Surg. Pathol. 35 2011 878 882